Veterinary Healthcare Market to Reach $102.4 Billion by 2035

Veterinary healthcare Market is projected to grow from $51.3 billion in 2025 to $102.4 billion by 2035, registering a CAGR of 7.2% during the forecast period. The market expansion is primarily driven by the rising global demand for animal protein, increasing pet ownership, and growing awareness regarding animal health and disease prevention. A key macro driver accelerating market growth is the surge in livestock production and zoonotic disease management. According to the Food and Agriculture Organisation (FAO), global meat production is expected to exceed 360 million tonnes annually, reflecting increased demand for efficient livestock healthcare solutions. Additionally, the World Health Organisation (WHO) highlights that over 60% of emerging infectious diseases are zoonotic, emphasising the critical need for veterinary pharmaceuticals, vaccines, and diagnostics. This growing burden of animal diseases directly fuels demand for advanced veterinary healthcare products, particularly vaccines and anti-infectives.

Browse the full report description of “Veterinary Healthcare Market Size, Share & Trends Analysis Report, By Product Type (Pharmaceuticals, Feed Additives, Diagnostics Products, Medical Devices), By Animal Type (Companion Animals, Livestock Animals, Aquatic Animals, Exotic & Zoo Animals), By Application Type (Infectious Diseases Treatment & Prevention, Parasitic Infections, Pain Management & Inflammation, Reproductive Health & Fertility Management, Nutritional Deficiency Management, Respiratory Disorders, Gastrointestinal Disorders, Dermatological Conditions), By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Retail Pharmacies, E-commerce / Online Veterinary Pharmacies, Government Supply & Livestock Programs), Forecast Period (2026-2035)” at https://www.omrglobal.com/industry-reports/veterinary-healthcare-market

From an end-user perspective, rising pet ownership is significantly contributing to market growth. Data from the OECD indicates a steady increase in companion animal adoption across developed economies, with pet healthcare spending growing consistently year-over-year. Moreover, the European Commission reports that over 70% of households in Europe own at least one pet, further strengthening demand for veterinary diagnostics, pharmaceuticals, and preventive care services. Among product types, the pharmaceuticals segment, particularly vaccines, is expected to witness the fastest growth due to increasing disease outbreaks and preventive healthcare initiatives. Veterinary vaccines (viral, bacterial, and combination) are gaining strong traction as governments and global health organizations push for disease control programs in livestock and companion animals. Several strategic developments have further strengthened the market landscape. Key industry developments include:

• In February 2026, Zoetis Inc. reported strong full-year 2025 results with $9.5 billion in revenue and continued expansion through new product approvals and geographic expansion initiatives.

• In October 2024, the U.S. Food and Drug Administration approved Elanco Animal Health’s Credelio Quattro, a new parasiticide treatment for dogs targeting multiple infections, strengthening its product portfolio.

Market Coverage

• The market number available for – 2025-2035
  • Base year- 2025
  • Forecast period- 2026-2035
  • Segment Covered-
  o By Pharmaceuticals
  o By Feed Additives
  o By Diagnostic Products
  o By Medical Devices
  • Competitive Landscape – Zoetis Inc., Boehringer Ingelheim, MSD Animal Health, Elanco Animal Health, and Virbac.

Key questions addressed by the report.

• What is the market growth rate?
  • Which segment and region dominate the market in the base year?
  • Which segment and region will project the fastest growth in the market?
  • Who is the leader in the market?
  • How are players addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Veterinary Healthcare Market Report Segment

By Product Type

• Pharmaceuticals
  o Anti-infectives
  o Anti-inflammatory drugs
  o Parasiticides (ectoparasiticides, endoparasiticides)
  o Vaccines (viral, bacterial, combination)
  o Hormones & Growth Promoters
  • Feed Additives
  o Vitamins & minerals
  o Amino acids
  o Probiotics & enzymes
  • Diagnostics Products
  o In-vitro diagnostic kits
  o Imaging consumables
  • Medical Devices
  o Surgical instruments
  o Monitoring devices
  o Diagnostic imaging systems

By Animal Type

• Companion Animals
  • Livestock Animals
  • Aquatic Animals
  • Exotic & Zoo Animals

By Application

• Infectious diseases treatment & prevention
  • Parasitic infections
  • Pain management & inflammation
  • Reproductive health & fertility management
  • Nutritional deficiency management
  • Respiratory disorders
  • Gastrointestinal disorders
  • Dermatological conditions

By Distribution Channel

• Veterinary Hospitals
  • Veterinary Clinics
  • Retail Pharmacies
  • E-commerce / Online veterinary pharmacies
  • Government supply & livestock programs

Global Veterinary Healthcare Market Report Segment by Region

North America

• United States
  • Canada

Europe

• UK
  • Germany
  • Italy
  • Spain
  • France
  • Russia
  • Rest of Europe

Asia-Pacific

• China
  • India
  • Japan
  • South Korea
  • Australia and New Zealand
  • ASEAN Economies
  • Rest of Asia-Pacific

Rest of the World

• Latin America
  • Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/veterinary-healthcare-market